System and method for distinguishing between hypoglycemia and hyperglycemia using an implantable medical device
AssigneePacesetter, Inc.
InventorRupinder Bharmi
Life of this patent
Estimating the term…
Loading patent…
AssigneePacesetter, Inc.
InventorRupinder Bharmi
Estimating the term…
Techniques are described for detecting and distinguishing among ischemia, hypoglycemia or hyperglycemia based on intracardiac electrogram (IEGM) signals. In one technique, these conditions are detected and distinguished based on an analysis of: the interval between the QRS complex and the peak of a T-wave (QTmax), the interval between the QRS complex and the end of a T-wave (QTend), alone or in combination with a change in ST segment elevation. By exploiting QTmax and QTend in combination with ST segment elevation, changes in ST segment elevation caused by hypo/hyperglycemia can be properly distinguished from changes caused by cardiac ischemia. In another technique, hyperglycemia and hypoglycemia are predicted, detected and/or distinguished from one another based on an analysis of the amplitudes of P-waves, QRS-complexes and T-waves within the IEGM. Appropriate warning signals are delivered and therapy is automatically adjusted.
A method for use with an implantable medical device for detecting one of hypoglycemia and hyperglycemia within a patient in which the device is implanted, said method comprising:
An implantable medical device comprising:
Dependencies are inferred from the claim text.